Infographic: intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration (VIEW 1 and VIEW 2)

Eye (Lond). 2024 Aug;38(Suppl 2):49-50. doi: 10.1038/s41433-023-02835-y. Epub 2023 Nov 28.
No abstract available

MeSH terms

  • Angiogenesis Inhibitors* / administration & dosage
  • Angiogenesis Inhibitors* / therapeutic use
  • Humans
  • Intravitreal Injections*
  • Receptors, Vascular Endothelial Growth Factor* / antagonists & inhibitors
  • Receptors, Vascular Endothelial Growth Factor* / therapeutic use
  • Recombinant Fusion Proteins* / administration & dosage
  • Recombinant Fusion Proteins* / therapeutic use
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors
  • Wet Macular Degeneration* / drug therapy

Substances

  • aflibercept
  • Receptors, Vascular Endothelial Growth Factor
  • Recombinant Fusion Proteins
  • Angiogenesis Inhibitors
  • Vascular Endothelial Growth Factor A
  • VEGFA protein, human